P-glycoprotein (ABCB1) - weak dipolar interactions provide the key to understanding allocrite recognition, binding, and transport

P-glycoprotein (ABCB1) is the first discovered mammalian member of the large family of ATP binding cassette (ABC) transporters. It facilitates the movement of compounds (called allocrites) across membranes, using the energy of ATP binding and hydrolysis. Here, we review the thermodynamics of allocrite binding and the kinetics of ATP hydrolysis by ABCB1. In combination with our previous molecular dynamics simulations, these data lead to a new model for allocrite transport by ABCB1. In contrast to previous models, we take into account that the transporter was evolutionarily optimized to operate within a membrane, which dictates the nature of interactions. Hydrophobic interactions drive lipid-water partitioning of allocrites, the transport process’s first step. Weak dipolar interactions (including hydrogen bonding, π-π stacking, and π-cation interactions) drive allocrite recognition, binding, and transport by ABCB1 within the membrane. Increasing the lateral membrane packing density reduces allocrite partitioning but enhances dipolar interactions between allocrites and ABCB1. Allocrite flopping (or reorientation of the polar part towards the extracellular aqueous phase) occurs after hydrolysis of one ATP molecule and opening of ABCB1 at the extracellular side. Rebinding of ATP re-closes the transporter at the extracellular side and expels the potentially remaining allocrite into the membrane. The high sensitivity of the steady-state ATP hydrolysis rate to the nature and number of dipolar interactions, as well as to the dielectric constant of the membrane, points to a flopping process, which occurs to a large extent at the membrane-transporter interface. The proposed unidirectional ABCB1 transport cycle, driven by weak dipolar interactions, is consistent with membrane biophysics.

[1]  K. Locher,et al.  Discovery and Characterization of Potent Dual P-Glycoprotein and CYP3A4 Inhibitors: Design, Synthesis, Cryo-EM Analysis, and Biological Evaluations. , 2021, Journal of medicinal chemistry.

[2]  K. Linton,et al.  ABCB1 Does Not Require the Side-Chain Hydrogen-Bond Donors Gln347, Gln725, Gln990 to Confer Cellular Resistance to the Anticancer Drug Taxol , 2021, International journal of molecular sciences.

[3]  Amanda F. Clouser,et al.  Cholesterol Asymmetrically Modulates the Conformational Ensemble of the Nucleotide-Binding Domains of P-Glycoprotein in Lipid Nanodiscs. , 2020, Biochemistry.

[4]  A. Seelig P-Glycoprotein: One Mechanism, Many Tasks and the Consequences for Pharmacotherapy of Cancers , 2020, Frontiers in Oncology.

[5]  Oded Lewinson,et al.  Structures of ABC transporters: handle with care , 2020, FEBS letters.

[6]  E. Tajkhorshid,et al.  Structural and functional diversity calls for a new classification of ABC transporters , 2020, FEBS letters.

[7]  R. Tampé,et al.  Structural and Mechanistic Principles of ABC Transporters. , 2020, Annual review of biochemistry.

[8]  S. Genovese,et al.  Citrus auraptene induces drug efflux transporter P-glycoprotein expression in human intestinal cells. , 2020, Food & function.

[9]  K. Levental,et al.  Plasma membranes are asymmetric in lipid unsaturation, packing, and protein shape , 2020, Nature Chemical Biology.

[10]  M. Gottesman,et al.  Multidrug transporters: recent insights from cryo-electron microscopy-derived atomic structures and animal models , 2020, F1000Research.

[11]  G. Hummer,et al.  Structure of Outward-Facing PglK and Molecular Dynamics of Lipid-Linked Oligosaccharide Recognition and Translocation. , 2019, Structure.

[12]  M. Gottesman,et al.  Revisiting the role of ABC transporters in multidrug-resistant cancer , 2018, Nature Reviews Cancer.

[13]  S. Ambudkar,et al.  Effects of a detergent micelle environment on P-glycoprotein (ABCB1)-ligand interactions , 2017, The Journal of Biological Chemistry.

[14]  S. Bernèche,et al.  Unidirectional Transport Mechanism in an ATP Dependent Exporter , 2017, ACS central science.

[15]  A. Seelig,et al.  How Phosphorylation and ATPase Activity Regulate Anion Flux though the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)* , 2016, The Journal of Biological Chemistry.

[16]  G. Szakács,et al.  A single active catalytic site is sufficient to promote transport in P-glycoprotein , 2016, Scientific Reports.

[17]  S. Ambudkar,et al.  Drug-protein hydrogen bonds govern the inhibition of the ATP hydrolysis of the multidrug transporter P-glycoprotein. , 2016, Biochemical pharmacology.

[18]  A. Seelig,et al.  Predicting Activators and Inhibitors of the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1) Based on Mechanistic Considerations. , 2015, Molecular pharmaceutics.

[19]  S. Bernèche,et al.  Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1). , 2015, Biochemistry.

[20]  Hiroyuki Noji,et al.  Diversity in ATP concentrations in a single bacterial cell population revealed by quantitative single-cell imaging , 2014, Scientific Reports.

[21]  R. Lill,et al.  Crystal Structures of Nucleotide-Free and Glutathione-Bound Mitochondrial ABC Transporter Atm1 , 2014, Science.

[22]  Stephen G Aller,et al.  Refined structures of mouse P-glycoprotein , 2013, Protein science : a publication of the Protein Society.

[23]  M. Geisler,et al.  Plant ABC Transporters , 2014, Signaling and Communication in Plants.

[24]  D. Hwang Cation-π Interaction , 2013 .

[25]  M. Battegay,et al.  The brain entry of HIV-1 protease inhibitors is facilitated when used in combination. , 2013, Molecular pharmaceutics.

[26]  R. Dawson,et al.  Sav1866 from Staphylococcus aureus and P-glycoprotein: similarities and differences in ATPase activity assessed with detergents as allocrites. , 2013, Biochemistry.

[27]  Tiago M. Ferreira,et al.  Cholesterol and POPC segmental order parameters in lipid membranes: solid state 1H-13C NMR and MD simulation studies. , 2013, Physical chemistry chemical physics : PCCP.

[28]  F. Sharom,et al.  Lipid bilayer properties control membrane partitioning, binding, and transport of p-glycoprotein substrates. , 2013, Biochemistry.

[29]  A. Seelig,et al.  P-glycoprotein-ATPase modulation: the molecular mechanisms. , 2012, Biophysical journal.

[30]  J. Killian,et al.  Probing the lipid-protein interface using model transmembrane peptides with a covalently linked acyl chain. , 2011, Biophysical journal.

[31]  I. Holland,et al.  ABC transporters, mechanisms and biology: an overview. , 2011, Essays in biochemistry.

[32]  G. Szakács,et al.  The controversial role of ABC transporters in clinical oncology. , 2011, Essays in biochemistry.

[33]  A. Seelig,et al.  Exploring the P-glycoprotein binding cavity with polyoxyethylene alkyl ethers. , 2010, Biophysical journal.

[34]  Shih-Chung Huang,et al.  Neurokinin-1 receptor antagonists: a comprehensive patent survey , 2010, Expert opinion on therapeutic patents.

[35]  J. Seelig,et al.  Lipid and peptide dynamics in membranes upon insertion of n-alkyl-beta-D-glucopyranosides. , 2010, Biophysical journal.

[36]  A. Seelig,et al.  P-glycoprotein substrate transport assessed by comparing cellular and vesicular ATPase activity. , 2010, Biochimica et biophysica acta.

[37]  Anna Seelig,et al.  Detergents as intrinsic P-glycoprotein substrates and inhibitors. , 2009, Biochimica et biophysica acta.

[38]  Ulf Norinder,et al.  Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs , 2009, Pharmaceutical Research.

[39]  Yue Weng,et al.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.

[40]  S. Hell,et al.  Direct observation of the nanoscale dynamics of membrane lipids in a living cell , 2009, Nature.

[41]  F. Sharom,et al.  Interaction of the P-glycoprotein multidrug efflux pump with cholesterol: effects on ATPase activity, drug binding and transport. , 2008, Biochemistry.

[42]  A. Seelig,et al.  P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle. , 2008, Biochemistry.

[43]  H. V. van Veen,et al.  Multidrug transport by the ABC transporter Sav1866 from Staphylococcus aureus. , 2008, Biochemistry.

[44]  Virgil L. Woods,et al.  Modest stabilization by most hydrogen-bonded side-chain interactions in membrane proteins , 2008, Nature.

[45]  Jue Chen,et al.  Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems , 2008, Microbiology and Molecular Biology Reviews.

[46]  Geoffrey Chang,et al.  Flexibility in the ABC transporter MsbA: Alternating access with a twist , 2007, Proceedings of the National Academy of Sciences.

[47]  Anna Seelig,et al.  The Role of Size and Charge for Blood–Brain Barrier Permeation of Drugs and Fatty Acids , 2007, Journal of Molecular Neuroscience.

[48]  K. Locher,et al.  Structure of the multidrug ABC transporter Sav1866 from Staphylococcus aureus in complex with AMP‐PNP , 2007, FEBS letters.

[49]  A. Seelig,et al.  P-Glycoprotein kinetics measured in plasma membrane vesicles and living cells. , 2007, Biochemistry.

[50]  H. Kato,et al.  Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. , 2007, The Biochemical journal.

[51]  F. Sharom Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1). , 2006, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[52]  J. Seelig,et al.  Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity. , 2006, Biophysical journal.

[53]  Grégori Gerebtzoff,et al.  In Silico Prediction of Blood-Brain Barrier Permeation Using the Calculated Molecular Cross-Sectional Area as Main Parameter , 2006, J. Chem. Inf. Model..

[54]  R. Dawson,et al.  Structure of a bacterial multidrug ABC transporter , 2006, Nature.

[55]  M. Detty,et al.  Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state. , 2006, Biochemistry.

[56]  H. Omote,et al.  Interaction of transported drugs with the lipid bilayer and P-glycoprotein through a solvation exchange mechanism. , 2006, Biophysical journal.

[57]  Anna Seelig,et al.  Quantification and characterization of P-glycoprotein-substrate interactions. , 2006, Biochemistry.

[58]  R. Himes,et al.  Single-site chemical modification at C10 of the baccatin III core of paclitaxel and Taxol C reduces P-glycoprotein interactions in bovine brain microvessel endothelial cells. , 2006, Bioorganic & medicinal chemistry letters.

[59]  D. Rigal,et al.  Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. , 2005, Biochemistry.

[60]  Y. Kimura,et al.  Local dielectric properties around polar region of lipid bilayer membranes , 2005, The Journal of Membrane Biology.

[61]  K. Linton,et al.  The ATP switch model for ABC transporters , 2004, Nature Structural &Molecular Biology.

[62]  I. V. Polozov,et al.  Liquid domains in vesicles investigated by NMR and fluorescence microscopy. , 2004, Biophysical journal.

[63]  I. Arkin,et al.  Experimental Measurement of the Strength of a Cα−H···O Bond in a Lipid Bilayer , 2004 .

[64]  J. Seelig,et al.  Membrane perturbation by the lipopeptide surfactin and detergents as studied by deuterium NMR , 2004 .

[65]  H. Omote,et al.  Transition State Analysis of the Coupling of Drug Transport to ATP Hydrolysis by P-glycoprotein* , 2003, Journal of Biological Chemistry.

[66]  A. Kabanov,et al.  An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[67]  F. Sharom,et al.  Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle. , 2003, Biochemistry.

[68]  F. Ataullakhanov,et al.  What Determines the Intracellular ATP Concentration , 2002, Bioscience reports.

[69]  H. Omote,et al.  A Novel Electron Paramagnetic Resonance Approach to Determine the Mechanism of Drug Transport by P-glycoprotein* , 2002, The Journal of Biological Chemistry.

[70]  G. Fink,et al.  Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration , 2002, Nature.

[71]  A. Seelig,et al.  Real-time monitoring of P-glycoprotein activation in living cells. , 2002, Biochemistry.

[72]  J. Seelig,et al.  Interactions of cyclosporines with lipid membranes as studied by solid-state nuclear magnetic resonance spectroscopy and high-sensitivity titration calorimetry. , 2002, Journal of pharmaceutical sciences.

[73]  L. Benet,et al.  Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. , 2002, The Journal of pharmacology and experimental therapeutics.

[74]  M. Gottesman,et al.  Overview: ABC Transporters and Human Disease , 2001, Journal of bioenergetics and biomembranes.

[75]  C. Higgins,et al.  The importance of cholesterol in maintenance of P-glycoprotein activity and its membrane perturbing influence , 2001, European Biophysics Journal.

[76]  F. Sharom,et al.  Phospholipid flippase activity of the reconstituted P-glycoprotein multidrug transporter. , 2001, Biochemistry.

[77]  F. Sharom,et al.  Exploring the structure and function of the P-glycoprotein multidrug transporter using fluorescence spectroscopic tools. , 2001, Seminars in cell & developmental biology.

[78]  A. Rzhetsky,et al.  The human ATP-binding cassette (ABC) transporter superfamily. , 2001, Genome research.

[79]  A. Holzenburg,et al.  The structure of the multidrug resistance protein 1 ( MRP 1 / ABCC 1 ) : crystallization and single-particle analysis * , 2001 .

[80]  Z. Sauna,et al.  The Mechanism of Action of Multidrug-Resistance-Linked P-Glycoprotein , 2001, Journal of bioenergetics and biomembranes.

[81]  F. Sharom,et al.  The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. , 1999, Biochemistry.

[82]  V. Ling,et al.  Stoichiometry of coupling of rhodamine 123 transport to ATP hydrolysis by P-glycoprotein. , 1998, European journal of biochemistry.

[83]  WD Stein Kinetics of the P‐glycoprotein, the multidrug transporter , 1998, Experimental physiology.

[84]  A. Seelig How does P-glycoprotein recognize its substrates? , 1998, International journal of clinical pharmacology and therapeutics.

[85]  A. Seelig A general pattern for substrate recognition by P-glycoprotein. , 1998, European journal of biochemistry.

[86]  C. Higgins,et al.  The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface. , 1997, Biochimica et biophysica acta.

[87]  T. Litman,et al.  Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity. , 1997, Biochimica et biophysica acta.

[88]  T. Litman,et al.  Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity. , 1997, Biochimica et biophysica acta.

[89]  T. Litman,et al.  ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines. , 1997, Biochimica et biophysica acta.

[90]  S. Ambudkar,et al.  Relation Between the Turnover Number for Vinblastine Transport and for Vinblastine-stimulated ATP Hydrolysis by Human P-glycoprotein* , 1997, The Journal of Biological Chemistry.

[91]  M. Wenk,et al.  Octyl-beta-D-glucopyranoside partitioning into lipid bilayers: thermodynamics of binding and structural changes of the bilayer. , 1997, Biophysical journal.

[92]  N. Ben-Tal,et al.  Free Energy of Amide Hydrogen Bond Formation in Vacuum, in Water, and in Liquid Alkane Solution , 1997 .

[93]  A. Seelig,et al.  Binding of substance P agonists to lipid membranes and to the neurokinin-1 receptor. , 1996, Biochemistry.

[94]  Y. Assaraf,et al.  Functional Reconstitution of P-glycoprotein Reveals an Apparent Near Stoichiometric Drug Transport to ATP Hydrolysis (*) , 1996, The Journal of Biological Chemistry.

[95]  M. Wenk,et al.  Paclitaxel partitioning into lipid bilayers. , 1996, Journal of pharmaceutical sciences.

[96]  A. E. Senior,et al.  The catalytic cycle of P‐glycoprotein , 1995, FEBS letters.

[97]  Y. Assaraf,et al.  Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. , 1995, European journal of biochemistry.

[98]  M. Gottesman,et al.  Interaction of bioactive hydrophobic peptides with the human multidrug transporter , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  A. E. Senior,et al.  Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein. , 1994, Biochemistry.

[100]  L. Becucci,et al.  The intrinsic pKa values for phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine in monolayers deposited on mercury electrodes. , 1994, Biophysical journal.

[101]  I. Pastan,et al.  Fluorescent cellular indicators are extruded by the multidrug resistance protein. , 1993, The Journal of biological chemistry.

[102]  A. E. Senior,et al.  Characterization of the adenosine triphosphatase activity of Chinese hamster P-glycoprotein. , 1993, The Journal of biological chemistry.

[103]  F. Sharom,et al.  The effects of lipids and detergents on ATPase-active P-glycoprotein. , 1993, Biochimica et biophysica acta.

[104]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[105]  I. Pastan,et al.  Characterization of the azidopine and vinblastine binding site of P-glycoprotein. , 1992, The Journal of biological chemistry.

[106]  J. W. Parce,et al.  The cytosensor microphysiometer: biological applications of silicon technology. , 1992, Science.

[107]  I. Pastan,et al.  Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[108]  F. Sharom,et al.  ATPase activity of partially purified P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. , 1992, Biochimica et biophysica acta.

[109]  R. Boucher,et al.  Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. , 1992, The Journal of biological chemistry.

[110]  M. Gottesman,et al.  Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.

[111]  J. Seelig,et al.  Nonclassical hydrophobic effect in membrane binding equilibria. , 1991, Biochemistry.

[112]  J. W. Parce,et al.  Continuous monitoring of receptor-mediated changes in the metabolic rates of living cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[113]  A. Seelig The use of monolayers for simple and quantitative analysis of lipid-drug interactions exemplified with dibucaine and substance P. , 1990, Cell biology international reports.

[114]  I. Pastan,et al.  Photosensitized labeling of a functional multidrug transporter in living drug-resistant tumor cells. , 1990, The Journal of biological chemistry.

[115]  J. Lankelma,et al.  Induction by verapamil of a rapid increase in ATP consumption in multidrug‐resistant tumor cells , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[116]  J. Seelig,et al.  Structure and dynamics of the phosphatidylcholine and the phosphatidylethanolamine head group in L‐M fibroblasts as studied by deuterium nuclear magnetic resonance. , 1987, The EMBO journal.

[117]  I. Pastan,et al.  Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[118]  J. Seelig,et al.  Phospholipid composition and organization of cytochrome c oxidase preparations as determined by 31P-nuclear magnetic resonance. , 1985, Biochimica et biophysica acta.

[119]  J. Seelig,et al.  Lipid solvation of cytochrome c oxidase. Deuterium, nitrogen-14, and phosphorus-31 nuclear magnetic resonance studies on the phosphocholine head group and on cis-unsaturated fatty acyl chains. , 1983, Biochemistry.

[120]  R. Balaban,et al.  Stoichiometry and coupling of active transport to oxidative metabolism in epithelial tissues. , 1981, The American journal of physiology.

[121]  H. S. Gutowsky,et al.  Protein-lipid interactions in biological and model membrane systems. Deuterium NMR of Acholeplasma laidlawii B, Escherichia coli, and cytochrome oxidase systems containing specifically deuterated lipids. , 1981, The Journal of biological chemistry.

[122]  J. Seelig,et al.  Lipid conformation in model membranes and biological membranes , 1980, Quarterly Reviews of Biophysics.

[123]  J. Op den Kamp Lipid asymmetry in membranes. , 1979, Annual review of biochemistry.

[124]  J. Seelig,et al.  Lipid-protein interaction in reconstituted cytochrome c oxidase/phospholipid membranes. , 1978, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[125]  H. S. Gutowsky,et al.  Deuterium nuclear magnetic resonance investigation of the effects of proteins and polypeptides on hydrocarbon chain order in model membrane systems. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[126]  D. Levitt,et al.  Theoretical calculation of the dielectric constant of a bilayer membrane. , 1977, Biophysical journal.

[127]  J. Seelig,et al.  Cholesterol-induced rod-like motion of fatty acyl chains in lipid bilayers a deuterium magnetic resonance study. , 1976, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[128]  R L Juliano,et al.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.

[129]  E. Newsholme,et al.  The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. , 1975, The Biochemical journal.

[130]  G. Vanderkooi,et al.  Evidence for boundary lipid in membranes. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[131]  R. Kornberg,et al.  Inside-outside transitions of phospholipids in vesicle membranes. , 1971, Biochemistry.

[132]  D E Green,et al.  Membrane structure. , 1971, Science.

[133]  O. Jardetzky,et al.  Simple Allosteric Model for Membrane Pumps , 1966, Nature.